M

MIRA Pharmaceuticals
D

MIRA

1.26000
USD
-0.07
(-5.26%)
مغلق
حجم التداول
16,419
الربح لكل سهم
-0
العائد الربحي
-
P/E
-3
حجم السوق
24,027,337
المقالات

العنوان: MIRA Pharmaceuticals

القطاع: Healthcare
الصناعة: Drug Manufacturers - General
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.